Showing results (1-10 of 89) with videos related to
Sort By:
Pageof 9
Breast Cancer Research : BCR|December 12, 2001
PTEN deficiency: a role in mammary carcinogenesisT Petrocelli, J M SlingerlandJournal of Cellular Physiology|September 1, 1991
Transforming activity of mutant human p53 allelesJ M Slingerland, S BenchimolNature Reviews. Cancer|February 8, 2014
Links between oestrogen receptor activation and proteolysis: relevance to hormone-regulated cancer therapyWen Zhou, Joyce M SlingerlandCell Cycle (Georgetown, Tex.)|July 10, 2003
Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progressionJiyong Liang, Joyce M SlingerlandCancer Research|December 19, 2024
DOT1L Mediates Stem Cell Maintenance and Represents a Therapeutic Vulnerability in CancerHetakshi Kurani, Joyce M SlingerlandAnnual Review of Medicine|November 6, 2012
Cytokines, obesity, and cancer: new insights on mechanisms linking obesity to cancer risk and progressionCandace A Gilbert, Joyce M SlingerlandBreast Cancer Research and Treatment|March 5, 1999
Prognostic implications of expression of the cell cycle inhibitor protein p27Kip1S Cariou, C Catzavelos, J M SlingerlandMolecular Endocrinology (Baltimore, Md.)|August 2, 2007
Long-range activation of GREB1 by estrogen receptor via three distal consensus estrogen-responsive elements in breast cancer cellsJun Sun, Zafar Nawaz, Joyce M SlingerlandThe Journal of Biological Chemistry|August 31, 2001
Constitutive MEK/MAPK activation leads to p27(Kip1) deregulation and antiestrogen resistance in human breast cancer cellsJ C Donovan, A Milic, J M SlingerlandNature Reviews. Cancer|March 21, 2008
The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapyIsabel M Chu, Ludger Hengst, Joyce M SlingerlandPageof 9